Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| South Sudan | $805.6K | 32.2% |
| Burundi | $413.2K | 16.5% |
| Mali | $336.9K | 13.5% |
| Cameroon | $219.9K | 8.8% |
| Japan | $169.5K | 6.8% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Somalia | $2.9K | 100.0% |
| Year | Export value |
|---|---|
| 2021 | $413.2K |
| 2022 | $510.4K |
| 2023 | $583K |
| 2024 | $727.8K |
| 2025 | $200.1K |
| 2026 | $64.1K |
China customs reports HS 300360 at the 8-digit level. 2 subheadings are published under it, and export values for each are available on request.
Bulk antimalarial medicaments formulated with artemisinin or its derivatives are classified here, provided they are not put up in measured doses or retail packings.
Antimalarial medicaments based on active principles other than artemisinin and its derivatives fall under this heading when supplied in bulk rather than measured doses or retail…
Public data shows up to 5 partner countries. Request all available countries, years, quantity fields, or HS8 detail in CSV.
HS 300360 is also written 3003.60. Values are in USD; the public series does not report tonnes or kg. Product scope: Medicaments containing antimalarial active principles specified in customs subheading notes, generally prepared for the treatment or prevention of malaria infections. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Antimalarial active (HS 300360) Export Data." https://chinadata.live/china-trade/hs/300360/
HS 300360 is also written 3003.60. Values are in USD; the public series does not report tonnes or kg. Product scope: Medicaments containing antimalarial active principles specified in customs subheading notes, generally prepared for the treatment or prevention of malaria infections. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Antimalarial active (HS 300360) Export Data." https://chinadata.live/china-trade/hs/300360/
China exported $223K of antimalarial active in the twelve months to August 2026, averaging $18.6K per month, based on official China customs statistics (HS 300360).
Medicaments containing antimalarial active principles specified in customs subheading notes, generally prepared for the treatment or prevention of malaria infections.
South Sudan, Burundi and Mali together account for 62% of the published total, out of 4 trading partners on record.
Annual exports declined by 52% between 2021 and 2025, from $413K to $200K.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.